High-Yield Parenting, Optimizing for Outcomes: Why Therapy Is a Smart Investment in Your Teen’s Future
Reframing therapy as a smart investment teens can make in themselves to build confidence and resilience, featuring insights from experts,...
Brain
Pusan National University Researchers Explore Smart Nanomaterials That Detect and Treat Traumatic Brain Injuries Simultaneously
BUSAN, South Korea, Nov. 12, 2025 /PRNewswire/ -- Traumatic brain injury (TBI) is one of the most serious public health...
We’re Awake 16 Hours a Day. We Spend 10 of Them Staring at Our Screens–and Most of Us Feel Powerless to Stop
Offline.now launches as a comprehensive digital wellness platform powered by behavioral data that shows confidence, not willpower, is the missing...
Lumus Geometric Waveguides Bring Surgical-Grade Brightness and Clarity to SnkeXR AR Glasses
High-performance geometric waveguides deliver industry-leading brightness, clarity, and ergonomics for clinical workflows. NESS ZIONA, Israel, Nov. 12, 2025 /PRNewswire/ -- Lumus,...
Corundum Neuroscience Invests in NextSense to Support Commercialization of Smartbuds
TEL AVIV, Israel, Nov. 12, 2025 /PRNewswire/ -- Corundum Neuroscience (CNS), the neuroscience venture builder and fund announced today they have...
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent...
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
- Former Chimerix (CMRX, acquired by Jazz for $935 million) Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch...
Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
Preclinical research to be conducted at the University of North Carolina at Chapel Hill (UNC) Annamycin will be used in...
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement...
Wearable Sensors Market to Reach $13.2 billion, Globally, by 2034 at 21.4% CAGR: Allied Market Research
The global wearable sensors market is experiencing rapid growth due to rise in integration of wearable sensors with smartphones and...
TEDCO’s Maryland Innovation Initiative Announces Recent Company Formation and Technology Assessment Awardees
Maryland Innovation Initiative awards more than $2 million across 14 projects COLUMBIA, Md., Nov. 10, 2025 /PRNewswire/ -- TEDCO, Maryland's...
Brainomix Recognized in Global Health Tech Competition for Its Innovative Brainomix 360 Stroke Technology
Company earns top recognition in the Science category for its stroke AI technology CHICAGO and OXFORD, England, Nov. 10, 2025...
Zenos Health Summit 2025 Concludes Transformative Three-Day Gathering of Global Longevity Leaders in Riyadh
Over 1,000 Global Leaders Convene for Inaugural Summit as Saudi Arabia Emerges as Hub for Wellness Innovation and Longevity Science...
Brain Balance Expands to Brooklyn, New York, Led by Veteran Educator and Advocate Sarah Weeks
NAPERVILLE, IL / ACCESS Newswire / November 10, 2025 / Brain Balance, a leading brain health and development program that...
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
Trillion-Dollar Digital Healthcare Transformations Shaped by AI, Quantum and Biotech Breakthroughs at GITEX GLOBAL
The world's largest tech and AI show brought groundbreaking innovations in healthcare, neurotech and life sciences to the forefront M42,...
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated: 59% risk reduction in ACM in...
MemoMaster Unveiled: How This Memo Master Cutting-Edge Brain Support Supplement Is Redefining Focus and Memory Health for the Digital Era
Boost memory, focus & mental clarity with MemoMaster – a clinically inspired brain supplement for sharper thinking, sustained energy &...
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% reduction in vomiting...
Hone Health Integrates Prenuvo Whole-Body MRI Scans to Power Preventive, Data-Driven Longevity Care
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Hone Health, the leader in longevity intelligence and personalized care, is teaming up with...